Abstract
Lithium (Li) reduces brain inositol levels. Berridge has suggested that this effect is related to Li's mechanism of action. It had previously been shown that pilocarpine causes a limbic seizure syndrome in lithium treated rats, and that these lithium-pilocarpine seizures are reversible by intracerebroventricular inositol administration to rats. We now show that although inositol passes the blood-brain barrier poorly, large doses of intraperitoneal (IP) inositol can also reverse Li-pilocarpine seizures. Using gas chromatography, IP inositol can raise brain inositol levels. Demonstration that inositol enters brain after peripheral administration provides a basis for possible pharmacological intervention in psychiatric disorders at the level of second messengers linked to the phosphatidylinositol cycle.
| Original language | English |
|---|---|
| Pages (from-to) | 341-343 |
| Number of pages | 3 |
| Journal | Pharmacology Biochemistry and Behavior |
| Volume | 49 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1 Jan 1994 |
Keywords
- Blood-brain barrier
- Inositol
- Li-pilocarpine seizures
- Lithium
ASJC Scopus subject areas
- Biochemistry
- Toxicology
- Pharmacology
- Clinical Biochemistry
- Biological Psychiatry
- Behavioral Neuroscience